Grupo de investigación traslacional en cáncer de pulmón

El Grupo de Investigación Traslacional en Cáncer de Pulmón (GITCaP) se dedica a la investigación y tratamiento de tumores torácicos, con un equipo multidisciplinar de oncólogos/as, cirujanos/as, patólogos/as, radiólogos/as, neumólogos/as y otros especialistas. Sus líneas de investigación se enfocan en identificar marcadores predictivos de eficacia de tratamientos y mejorar la supervivencia y calidad de vida de sus pacientes. Además, colaboran en ensayos clínicos y proyectos sobre microbiota, biomarcadores en sangre, cáncer en no fumadores/as y el impacto del radón. También investigan el uso de inteligencia artificial en radiología y la promoción del ejercicio físico para reducir la inflamación.

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Busch F, Hoffmann L, Xu L, Zhang LJ, Hu B, García-Juárez I, Toapanta-Yanchapaxi LN, Gorelik N, Gorelik V, Rodriguez-Granillo GA, Ferrarotti C, Cuong NN, Thi CAP, Tuncel M, Kaya G, Solis-Barquero SM, Mendez Avila MC, Ivanova NG, Kitamura FC, Hayama KYI, Puntunet Bates ML, Torres PI, Ortiz-Prado E, Izquierdo-Condoy JS, Schwarz GM, Hofstaetter JG, Hide M, Takeda K, Peric B, Pilko G, Thulesius HO, Lindow T, Kolawole IK, Olatoke SA, Grzybowski A, Corlateanu A, Iaconi OS, Li T, Domitrz I, Kepczynska K, Mihalcin M, Fašaneková L, Zatonski T, Fulek K, Molnár A, Maihoub S, da Silva Gama ZA, Saba L, Sountoulides P, Makowski MR, Aerts HJWL, Adams LC, Bressem KK, Navarro ÁA, Águas C, Aineseder M, Alomar M, Al Sliman R, Anand G, Angkurawaranon S, Aoki S, Arkoh S, Ashraf G, Astri Y, Bakhshi S, Bayramov NY, Billis A, Bitencourt AGV, Bolejko A, Bollas Becerra AJ, Bwambale J, Capela A, Cau R, Chacon-Acevedo KR, Chaunzwa TL, Chojniak R, Clements W, Cuocolo R, Dahlblom V, Sousa KM, Villarrubia JE, Desai VB, Dhakal AK, Dignum V, Andrade RGF, Ferraioli G, Ganguly S, Garg H, Savevska CG, Radovikj MG, Gkartzoni A, Gorospe L, Griffin I, Hadamitzky M, Ndahiro MH, Hering A, Hochhegger B, Huseynova MR, Ishida F, Jha N, Jiang L, Kader R, Kavnoudias H, Klein C, Kolostoumpis G, Koshy A, Kruger NA, Löser A, Lucijanic M, Mantziari D, Margue G, McFadden S, Miyake M, Morakote W, Ngabonziza I, Nguyen TT, Niehues SM, Nortje M, Palaian S, Pentara NV, de Almeida RPP, Poma G, Purwoko M, Pyrgidis N, Rafailidis V, Rainey C, Ribeiro JC, Agudelo NR, Sado K, Saidman JM, Saturno-Hernandez PJ, Suryadevara V, Schulz GB, Soric E, Soto-Pérez-Olivares J, Stanzione A, Struck JP, Takaoka H, Tanioka S, Huyen TTM, Truhn D, van Dijk EHC, van Wijngaarden P, Wang YC, Weidlich M, Zhang S.

    Multinational Attitudes Toward AI in Health Care and Diagnostics Among Hospital Patients.

    Jama Network Open . 8(6): .

    [doi:10.1001/jamanetworkopen.2025.14452]

  • Chamorro-Pérez J, Lage Y, Albarrán-Fernández V, Rosero-Rodríguez DI, Agudo P, Martínez-Vives P, Olmedo ME, Gómez-Rueda A, García-Pardo M, Garrido-López P.

    Nonbacterial Thrombotic Endocarditis (NBTE) Treated With Crizotinib in Lung Adenocarcinoma Harboring ROS-1 Rearrangement: Two Case Report and Review of Literature.

    CLINICAL LUNG CANCER . 26(4): .

    [doi:10.1016/j.cllc.2025.02.005]

  • Mittal A, Everest L, Patel D, Zhan LJ, Brown MC, Zaeimi F, Schmid S, Khan K, Dietrich K, Balaratnam K, de Santayana MGP, Eng L, Sacher AG, Shepherd FA, Leighl NB, Cho J, De Perrot M, Liu G, Bradbury P.

    Health Utility and Symptom Scores in Patients With Advanced Malignant Pleural Mesothelioma Treated in a Real-World Setting.

    Jto Clinical And Research Reports . 6(6): 100802-100802.

    [doi:10.1016/j.jtocrr.2025.100802]

  • García-Pardo M, García de Herreros M, Laguna JC, Gorría T, Lage Y, Gómez A, Olmedo ME, Garrido P, Albarran-Artahona VM, Arcocha A, Teixido C, Reguart N, Navarro A, Auclin E, Nahorski MS, Howarth K, Planchard D, Besse B, Leighl NB, Mezquita L.

    Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients With Advanced Lung Squamous Cell Carcinoma (SQUIN).

    CLINICAL LUNG CANCER . 26(4): .

    [doi:10.1016/j.cllc.2025.02.007]

  • Chiang AC, Olmedo Garcia ME, Carlisle JW, Dowlati A, Reguart N, Felip E, Jost PJ, Steeghs N, Stec R, Gadgeel SM, Loong HH, Jiang W, Hamidi A, Parkes A, Paz-Ares L.

    Safety of tarlatamab with 6-8-h outpatient versus 48-h inpatient monitoring during cycle 1: DeLLphi-300 phase 1 substudy.

    ESMO open . 10(4): 104538-104538.

    [doi:10.1016/j.esmoop.2025.104538]

  • Sereno M, Collazo-Lorduy A, Garitaonaindia Y, Gómez de Antonio D, Baena Espinar J, Aguado de la Rosa C, Cruz Castellanos P, Falagán Martínez S, Chara Valverde LE, López-Castro R, López-Martin A, Rubio-Pérez J, Gómez Rueda A, Traseira Puchol C, Mielgo Rubio X, Losada Vila B, Rogado J, Bernal Hertfelder E, Gutiérrez Sainz L, Campo-Cañaveral JL, Romano I, Thuissard I, Rubio Romero G, Casado Sáenz E.

    Analysis of operability parameter changes in neoadjuvant treatment with chemotherapy and anti-PD-1/PD-L1.

    Cancer Treatment and Research Communications . 43: 100910-100910.

    [doi:10.1016/j.ctarc.2025.100910]

  • Solomon BJ, Tan DSW, de Castro G Jr, Cobo M, Garassino MC, Zhang J, Johnson BE, Lee JM, Garrido P, Butler AA, Pelletier MR, Savchenko A, Ji L, Brase JC, Caparica R, Demanse D, Wu J, Bossen C, Mok T.

    The Impact of the Tumor Microenvironment on the Effect of IL-1ß Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials.

    Cancer Research Communications . 5(4): 632-646.

    [doi:10.1158/2767-9764.CRC-24-0490]

  • García-Latorre R, Gorospe L, González-Huete A.

    Right extrapleural hematoma due to thoracic trauma. The extrapleural fat sign.

    JORNAL BRASILEIRO DE PNEUMOLOGIA . 51(1): .

    [doi:10.36416/1806-3756/e20250027]

  • Gorospe L, Arrieta P, Barbolla-Díaz I, Mirambeaux-Villalona RM, Montelongo-Martín A.

    Bronchial anthracofibrosis beyond bronchial involvement causing pulmonary artery stenosis.

    LUNG INDIA . 42(2): 161-162.

    [doi:10.4103/lungindia.lungindia_99_24]

  • Salgado-Parente A, deVicente AG, Alarcón-Rodríguez J, Rivero Jiménez N.

    Cervical aortic arch: a rare congenital anomaly.

    Anales De Pediatria . 102(1): 503697-503697.

    [doi:10.1016/j.anpede.2024.503697]

  • Trujillo JC, Soriano JB, Marzo M, Higuera O, Gorospe L, Pajares V, Olmedo ME, Arrabal N, Flores A, García JF, Crespo M, Carcedo Rodriguez D, Heuser C, Obradovic MM, Olghi N, Choman EN, Seijo LM.

    Cost-effectiveness of a machine learning risk prediction model (LungFlag(TM)) in the selection of high-risk individuals for non-small cell lung cancer screening in Spain.

    Journal of medical economics . : 1-16.

    [doi:10.1080/13696998.2024.2444781]

  • Cortés-Salgado A, Serrano JJ, Cordero Pereda D, Menacho M, del Rey JM, Del Campo-Albendea L, Saavedra C, Chamorro J, Rosero D, Sotoca P, Guillén-Ponce C, Guerra E, Fernández-Abad M, López-Miranda E, Martínez-Jáñez N, Gion M, Salazar MT, Agudo-Quílez P, Garrido P, Alonso Salinas GL.

    Anthracyclines-induced cardiotoxicity in patients with early breast cancer carrying germline BRCA1/2 mutation: the BRCAN study.

    ONCOLOGIST . : .

    [doi:10.1093/oncolo/oyae299]

  • Villanueva Campos A, Canales Lachén E, Suevos Ballesteros C, Alarcón Rodríguez J.

    Multi-energy CT and iodinated contrast.

    Radiologia . 66 Suppl 2: .

    [doi:10.1016/j.rxeng.2024.03.011]

  • González-Castro S, Cadavid-Fernández N, Gorospe Sarasúa L.

    Silicone-induced Lymphadenopathy Mimicking Metastatic Lung Cancer.

    ARCHIVOS DE BRONCONEUMOLOGIA . : .

    [doi:10.1016/j.arbres.2024.10.013]

  • Planchard D, Wolf J, Solomon B, Sebastian M, Wermke M, Heist RS, Sun JM, Min Kim T, Reguart N, Sanmamed MF, Felip E, Garrido P, Santoro A, Bootle D, Couillebault XM, Gaur A, Mueller C, Poggio T, Yang J, Moschetta M, Dooms C.

    A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer.

    Lung Cancer . 197: 107964-107964.

    [doi:10.1016/j.lungcan.2024.107964]

  • Santoro A, Pilar G, Tan DSW, Zugazagoitia J, Shepherd FA, Bearz A, Barlesi F, Kim TM, Overbeck TR, Felip E, Cai C, Eddy S, McCulloch T, Schaefer ES.

    Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC.

    Bmc Cancer . 24(1): 1307-1307.

    [doi:10.1186/s12885-024-12841-2]

  • Isla D, Álvarez R, Arnal M, Arriola E, Azkarate A, Azkona E, García-Campelo R, Garrido P, Nadal E, Ortega AL, Carcedo D, Crespo M, Lavara J, Córcoles F, Bernabé R.

    Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysis.

    Journal of medical economics . 27(1): 1379-1387.

    [doi:10.1080/13696998.2024.2413289]

  • Carretero-Barrio I, Pijuan L, Illarramendi A, Curto D, López-Ríos F, Estébanez-Gallo Á, Castellvi J, Granados-Aparici S, Compañ-Quilis D, Noguera R, Esteban-Rodríguez I, Sánchez-Güerri I, Ramos-Guerra AD, Ortuño JE, Garrido P, Ledesma-Carbayo MJ, Benito A, Palacios J.

    Concordance in the estimation of tumor percentage in non-small cell lung cancer using digital pathology.

    SCIENTIFIC REPORTS . 14(1): 24163-24163.

    [doi:10.1038/s41598-024-75175-w]